Stockscreener 앱 받기
0.987
3.24%
-0.033
시간 외 거래:
.97
-0.017
-1.72%
전일 마감가:
$1.02
열려 있는:
$1.02
하루 거래량:
26,690
Relative Volume:
0.03
시가총액:
$4.21M
수익:
-
순이익/손실:
$-6.78M
주가수익비율:
-0.0231
EPS:
-42.6996
순현금흐름:
$-4.67M
1주 성능:
+1.74%
1개월 성능:
-4.78%
6개월 성능:
-27.43%
1년 성능:
-17.06%
1일 변동 폭
$0.9701
$1.02
1주일 범위
$0.9504
$1.03
52주 변동 폭
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
CMND을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.987 | 5.17M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Clearmind Medicine Inc. stock chart pattern explainedBollinger Band Squeeze and Expansion Analysis - Newser
Clearmind Medicine Inc. stock retracement – recovery analysisFree Confirmed Setup With Expert Accuracy - Newser
Can volume confirm reversal in Clearmind Medicine Inc.Real Market Tracker with Price Action Tools - Newser
Clearmind Medicine Inc. stock trendline breakdownAI Generated Buy/Sell Signal Forecast - Newser
Is it time to cut losses on Clearmind Medicine Inc.Buy List With Technical Entry Triggers - Newser
Should you wait for a breakout in Clearmind Medicine Inc.Price Spike Prediction for Active Traders - Newser
Risk vs reward if holding onto Clearmind Medicine Inc.Daily Pick Forecast with Entry Zones - Newser
Published on: 2025-08-09 23:23:05 - Newser
Why Clearmind Medicine Inc. stock attracts strong analyst attentionFree Alert Feed for Momentum Based Picks - Newser
How Clearmind Medicine Inc. stock performs during market volatilityFree Community Entry Consensus Trade Ideas - Newser
Short interest data insights for Clearmind Medicine Inc.Capital Safe Picks with Consistent Gains - Newser
Institutional scanner results for Clearmind Medicine Inc.Future Growth Stock Forecasting Strategy - Newser
Will Clearmind Medicine Inc. benefit from macro trendsSmart Money Strategy for Growth Stocks - Newser
Can you recover from losses in Clearmind Medicine Inc.Buy and Hold Return Summary with Charts - Newser
Can Clearmind Medicine Inc. rally from current levelsSummary of Reliable Long-Term Trade Models - Newser
How to use a screener to detect Clearmind Medicine Inc. breakoutsTrend Analysis for Safer Market Entries - Newser
How Clearmind Medicine Inc. stock reacts to Fed policy changesHigh Win Rate Trading Opportunities Detected - metal.it
Clearmind Medicine Inc. stock outlook for YEARTechnical Insight Guide for Safer Trades - Newser
SciSparc-Clearmind collab leads to international patent application - TipRanks
Clearmind announces publication of international patent application under PCT - TipRanks
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - The Manila Times
Clearmind announces patent application for metabolic syndrome treatment - Investing.com
Clearmind announces patent application for metabolic syndrome treatment By Investing.com - Investing.com South Africa
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
Can a trend reversal in Clearmind Medicine Inc. lead to recoveryAlpha Generation Strategy with Low Volatility - Newser
Exit strategy if you’re trapped in Clearmind Medicine Inc.Free Investment Playbook for Growing Markets - Newser
Does Clearmind Medicine Inc. show high probability of reboundWeekly Breakout Forecast with Entry Zones - Newser
Clearmind Medicine receives IRB approval for phase 1/2a clinical trial for alcohol use disorder - MarketScreener
Clearmind Medicine Receives IRB Approval For Phase 1/2a Clinical Trial For Alcohol Use Disorder - TradingView
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center - The Manila Times
Clearmind Medicine Receives IRB Approval for Phase 1/2a AUD Trial - AInvest
Clearmind Medicine Receives IRB Approval for Phase 1/2a Trial of CMND-100 for AUD Treatment at Hadassah Medical Center - AInvest
What makes Clearmind Medicine Inc. stock price move sharplyFree Smart Trend Trading with Weekly Signals - Newser
Clearmind Medicine Inc (CMND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):